Reflectance Medical Inc. (RMI) has developed the Mobile CareGuide™ sensor platform to noninvasively and continuously assess patient metabolic status with the goal of bringing ICU level monitoring capability to patients in the emergency department and outside the hospital.
Mobile CareGuide is different from the current crop of sensors used in mobile health applications, going beyond standard vital sign measures such as blood pressure, heart rate and pulse oximetry, to directly provide information on tissue health.
CareGuide will initially be marketed for military and civilian critical care inside and outside the hospital, allowing for prompt medical attention in settings where it can make the biggest difference in saving lives, reducing complications and lowering hospital costs.
Additionally, CareGuide is expected to help clinicians manage patients with cardiac dysfunction both in and out of the hospital, with the goal of reducing treatment costs by avoiding or shortening hospital visits.
RMI is bringing its technology to market through strategic partnerships with world leaders in these targeted application areas.